 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/26/2025 |
$0.84 |
$0.91 |
$0.83 |
$0.89 |
525.40K | | 11/28/2025 |
$0.86 |
$0.94 |
$0.86 |
$0.92 |
223.70K | | 12/01/2025 |
$0.85 |
$0.86 |
$0.78 |
$0.80 |
2.25M | | 12/02/2025 |
$0.80 |
$0.80 |
$0.72 |
$0.73 |
2.10M | | 12/03/2025 |
$7.75 |
$8.91 |
$7.15 |
$8.70 |
175.10K |
|
|
| Sutro Biopharma is a clinical-stage oncology company developing site-specific and antibody drug conjugates (ADCs) enabled by its proprietary integrated cell-free protein synthesis platform, XpressCF®, and its site-specific conjugation platform, XpressCF+®. Co.'s product candidate is STRO-002, or luveltamab tazevibulin, an ADC directed against folate receptor-alpha (FolRa) for patients with FolRa-expressing cancers, including ovarian cancer. Co.'s other product candidate is STRO-001, an ADC directed against CD74, for patients with B-cell malignancies, such as multiple myeloma and non-Hodgkin lymphoma. Co. also has a preclinical product candidate, STRO-003, which is a single homogeneous ADC. | |
|
Sutro Biopharma (STRO) has the following price history information. Looking back at STRO historical stock prices for the last five trading days, on November 26, 2025, STRO opened at $0.84, traded as high as $0.91 and as low as $0.83, and closed at $0.89. Trading volume was a total of 525.40K shares. On November 28, 2025, STRO opened at $0.86, traded as high as $0.94 and as low as $0.86, and closed at $0.92. Trading volume was a total of 223.70K shares. On December 01, 2025, STRO opened at $0.85, traded as high as $0.86 and as low as $0.78, and closed at $0.80. Trading volume was a total of 2.25M shares. On December 02, 2025, STRO opened at $0.80, traded as high as $0.80 and as low as $0.72, and closed at $0.73. Trading volume was a total of 2.10M shares. On December 03, 2025, STRO opened at $7.75, traded as high as $8.91 and as low as $7.15, and closed at $8.70. Trading volume was a total of 175.10K shares.
STRO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sutro Biopharma shares, starting with a $10,000 purchase of STRO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/28/2018 |
|
| End date: |
12/03/2025 |
|
| Start price/share: |
$150.00 |
|
| End price/share: |
$8.70 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-94.20% |
|
| Average Annual Total Return: |
-32.71% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$580.23 |
|
| Years: |
7.19 |
|
|
|
| Date |
Close |
| 11/26/2025 | $0.89 | | 11/28/2025 | $0.92 | | 12/01/2025 | $0.80 | | 12/02/2025 | $0.73 | | 12/03/2025 | $8.70 |
|
|
Free STRO Email Alerts:
